Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential

Abstract Urolithin A (UA, 1), a gut microbiota postbiotic metabolite is attributed to express interesting biological activities indicated by in vitro, in vivo and clinical studies. Due to its strong anti-inflammatory properties it is considered as a promising lead molecule for further drug developme...

Full description

Bibliographic Details
Main Authors: Maciej Korczak, Piotr Roszkowski, Sebastian Granica, Jakub P. Piwowarski
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-15870-8
_version_ 1828775069005905920
author Maciej Korczak
Piotr Roszkowski
Sebastian Granica
Jakub P. Piwowarski
author_facet Maciej Korczak
Piotr Roszkowski
Sebastian Granica
Jakub P. Piwowarski
author_sort Maciej Korczak
collection DOAJ
description Abstract Urolithin A (UA, 1), a gut microbiota postbiotic metabolite is attributed to express interesting biological activities indicated by in vitro, in vivo and clinical studies. Due to its strong anti-inflammatory properties it is considered as a promising lead molecule for further drug development, however, its strong phase II metabolism, severely limits its oral application. Therefore, monoesterified UA derivatives with selected NSAIDs: ibuprofen (Mix 3a/3b), mefenamic acid (Mix 4a/4b), diclofenac (Mix 5a/5b) and aspirin (Mix 6a/6b) were designed. Performed array of stability assays indicated Mix 4a/4b as a most suitable candidate for further studies due to its exceptional stability in human plasma. Thus, we evaluated effects of Mix 4a/4b on cell viability as well as the impact on cytokines secretion in THP-1 derived macrophages and compared it to UA. At high concentration (50 µM) Mix 4a/4b expressed a cytotoxic effect, however at concentration of 5 µM it significantly suppressed TNF-α secretion, and significantly increased ani-inflammatory IL-10 secretion at 10 µM without affecting cell viability. This work has led to selection of a novel UA derivatives, which are stable in solutions and in human plasma as well as posess anti-inflammatory activity towards THP-1 macrophages at non-cytotoxic concentrations.
first_indexed 2024-12-11T15:32:33Z
format Article
id doaj.art-8ade1e4cf42e4ca8b1716f34df24c26d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-11T15:32:33Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8ade1e4cf42e4ca8b1716f34df24c26d2022-12-22T01:00:01ZengNature PortfolioScientific Reports2045-23222022-07-0112111510.1038/s41598-022-15870-8Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potentialMaciej Korczak0Piotr Roszkowski1Sebastian Granica2Jakub P. Piwowarski3Microbiota Lab, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of WarsawLaboratory of Natural Products Chemistry, Faculty of Chemistry, University of WarsawMicrobiota Lab, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of WarsawMicrobiota Lab, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of WarsawAbstract Urolithin A (UA, 1), a gut microbiota postbiotic metabolite is attributed to express interesting biological activities indicated by in vitro, in vivo and clinical studies. Due to its strong anti-inflammatory properties it is considered as a promising lead molecule for further drug development, however, its strong phase II metabolism, severely limits its oral application. Therefore, monoesterified UA derivatives with selected NSAIDs: ibuprofen (Mix 3a/3b), mefenamic acid (Mix 4a/4b), diclofenac (Mix 5a/5b) and aspirin (Mix 6a/6b) were designed. Performed array of stability assays indicated Mix 4a/4b as a most suitable candidate for further studies due to its exceptional stability in human plasma. Thus, we evaluated effects of Mix 4a/4b on cell viability as well as the impact on cytokines secretion in THP-1 derived macrophages and compared it to UA. At high concentration (50 µM) Mix 4a/4b expressed a cytotoxic effect, however at concentration of 5 µM it significantly suppressed TNF-α secretion, and significantly increased ani-inflammatory IL-10 secretion at 10 µM without affecting cell viability. This work has led to selection of a novel UA derivatives, which are stable in solutions and in human plasma as well as posess anti-inflammatory activity towards THP-1 macrophages at non-cytotoxic concentrations.https://doi.org/10.1038/s41598-022-15870-8
spellingShingle Maciej Korczak
Piotr Roszkowski
Sebastian Granica
Jakub P. Piwowarski
Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
Scientific Reports
title Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
title_full Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
title_fullStr Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
title_full_unstemmed Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
title_short Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential
title_sort conjugates of urolithin a with nsaids their stability cytotoxicity and anti inflammatory potential
url https://doi.org/10.1038/s41598-022-15870-8
work_keys_str_mv AT maciejkorczak conjugatesofurolithinawithnsaidstheirstabilitycytotoxicityandantiinflammatorypotential
AT piotrroszkowski conjugatesofurolithinawithnsaidstheirstabilitycytotoxicityandantiinflammatorypotential
AT sebastiangranica conjugatesofurolithinawithnsaidstheirstabilitycytotoxicityandantiinflammatorypotential
AT jakubppiwowarski conjugatesofurolithinawithnsaidstheirstabilitycytotoxicityandantiinflammatorypotential